摘要
非ST段抬高型急性冠状动脉综合征(NSTEACS)中高危患者,早期介入和强化抗栓药物治疗是最佳选择,对于低危患者,早期介入或选择介入都可行。欧洲心脏病协会指南认为NSTEACS症状反复发作,并有高危因素,Grace风险评分>109分,推荐于发病72h内行介入治疗;Grace风险评分>140分,建议24h内行介入治疗;对并发难治性心绞痛、心力衰竭、恶性心律失常者建议发病2h内介入治疗。
High-risk patients with non-ST-segment elevation acute coronary syndrome(NSTEACS) are recommended to choose early intervention and strengthened antithrombotic drug therapy.While for low-risk patients,early or elective intervention are feasible.European Society of Cardiology guidelines suggested that if NSTEACS patients with recurrent symptoms,high risk factors and Grace risk score 109 points,intervention should be recommended within 72 h from the onset;if the grace risk score 140 points,the intervention should be recommended within 25 h from the onset;if NSTEACS patients complicated with refractory heart angina,heart failure,and malignant arrhythmia,the intervention is recommended within 2 h from the onset.
出处
《临床心血管病杂志》
CAS
CSCD
北大核心
2012年第1期15-18,共4页
Journal of Clinical Cardiology